Quarterly report [Sections 13 or 15(d)]

Supplemental Condensed Consolidated Balance Sheet Information (Tables)

v3.25.3
Supplemental Condensed Consolidated Balance Sheet Information (Tables)
9 Months Ended
Sep. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

 

September 30,
2025

 

 

December 31,
2024

 

Accrued consulting

 

$

266,291

 

 

$

202,379

 

Accrued compensation

 

 

2,109,933

 

 

 

999,303

 

Accrued research and development

 

 

1,163,993

 

 

 

1,397,348

 

Accrued other

 

 

116,166

 

 

 

81,000

 

Total accrued expenses and other current liabilities

 

$

3,656,383

 

 

$

2,680,030